| Gene symbol | IL3RA | Synonyms | CD123, IL-3R-alpha, IL3R, IL3RAY, IL3RX, IL3RY, hIL-3Ra | Type of gene | protein-coding |
| Chromosome | X|Y | Map location | X;Y | dbXrefs | |
| Description | interleukin 3 receptor subunit alpha | ||||
| GTO ID | GTC0847 |
| Trial ID | ChiCTR2000029672 |
| Disease | Acute Myeloid Leukemia | Blastic Plasmacytoid Dendritic Cell Neoplasm |
| Altered gene | CD123 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | Chimeric Antigen Receptor-Transduced T Cell (CAR-T) Therapy for Relapsed or Refractory CD123+ Acute Myeloid Leukemia and BPDCN |
| Year | 2020 |
| Country | China |
| Company sponsor | Beijing Shijitan Hospital Affiliated to Capital Medical University |
| Cohort 1 | |||||||
|
|||||||